Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Sep 09 2025

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 09, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL Single-Dose Prefilled Syringe".

View Attachment